Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
0(0%)
Results Posted
50%(1 trials)

Phase Distribution

Ph not_applicable
3
75%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution3 total trials
N/ANon-phased studies
3(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Active(1)
Completed(2)
Other(1)

Detailed Status

Completed2
Not yet recruiting1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A3 (100.0%)

Trials by Status

not_yet_recruiting125%
unknown125%
completed250%

Recent Activity

0 active trials
Showing 4 of 4
not_yet_recruiting

Restricted or Liberal Fluid for Haemodynamic Resuscitation in Sepsis

NCT05453565
unknownnot_applicable

The Effect of Increasing the Mean Arterial Pressure on the Microcirculation and the Prognosis of Patients With Septic Shock

NCT04136080
completednot_applicable

Optimal VAsopressor titraTION Pilot Randomized Controlled Trial

NCT01800877
completednot_applicable

Furosemide Stress Test Guiding Initiation of Renal Replacement Therapy

NCT02730117

Clinical Trials (4)

Showing 4 of 4 trials
NCT05453565

Restricted or Liberal Fluid for Haemodynamic Resuscitation in Sepsis

Not Yet Recruiting
NCT04136080Not Applicable

The Effect of Increasing the Mean Arterial Pressure on the Microcirculation and the Prognosis of Patients With Septic Shock

Unknown
NCT01800877Not Applicable

Optimal VAsopressor titraTION Pilot Randomized Controlled Trial

Completed
NCT02730117Not Applicable

Furosemide Stress Test Guiding Initiation of Renal Replacement Therapy

Completed

All 4 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
4